Stopping Enzalutamide May Not Impact Quality of Life in Prostate Cancer Subset

1 year ago 129

Patients with biochemically recurrent nonmetastatic hormone-sensitive prostate cancer who are responding well to an enzalutamide regimen may be able to stop treatment with an impact to their quality of life.

1. Homepage
2. Cancer
3. Stopping Enzalutamide May Not Impact Quality of Life in Prostate Cancer Subset